| Literature DB >> 23959774 |
Joyce K Thompson1, Catherine M Westbom, Arti Shukla.
Abstract
Malignant mesothelioma (MM) is an aggressive cancer of the mesothelium caused by asbestos. Asbestos use has been reduced but not completely stopped. In addition, natural or man-made disasters will continue to dislodge asbestos from old buildings into the atmosphere and as long as respirable asbestos is available, MM will continue to be a threat. Due to the long latency period of MM development, it would still take decades to eradicate this disease if asbestos was completely removed from our lives today. Therefore, there is a need for researchers and clinicians to work together to understand this deadly disease and find a solution for early diagnosis and treatment. This article focuses on developmental mechanisms as well as current therapies available for MM.Entities:
Keywords: ASBESTOS; INFLAMMATION; MALIGNANT MESOTHELIOMA; MESOTHELIUM
Mesh:
Substances:
Year: 2014 PMID: 23959774 PMCID: PMC3856563 DOI: 10.1002/jcb.24642
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429